April 30, 2020 / 5:41 AM / a month ago

BRIEF-Evotec Announces Collaboration To Develop Covid-19 Antibodies

April 30 (Reuters) - Evotec SE:

* SUBSIDIARY JUST EVOTEC BIOLOGICS HAS ENTERED INTO A PARTNERSHIP WITH OLOGY BIO FOR EVALUATION AND ANALYTICAL CHARACTERISATION OF ANTIBODIES AGAINST SARS-COV-2

* TO DEVELOP, AND MANUFACTURE MONOCLONAL ANTIBODIES FOR TREATMENT AND PREVENTION OF INFECTIONS WITH SARS-COV-2

* WORK IS SUPPORTED BY OFFICE OF ASSISTANT SECRETARY OF DEFENSE FOR HEALTH AFFAIRS WITH FUNDING FROM DEFENSE HEALTH AGENCY

* UNDER TERMS OF AGREEMENT, JUST EVOTEC BIOLOGICS WILL ACT AS A SUBCONTRACTOR TO OLOGY BIO AND UTILISE ITS IN SILICO TOOLSET TO SCREEN A PANEL OF ANTI-SARS-COV-2 ANTIBODIES PROVIDED BY OLOGY BIO THAT WERE GENERATED FROM CONVALESCING COVID-19 PATIENTS

* NO FINANCIAL DETAILS OF AGREEMENT WERE DISCLOSED

* APPLYING OUR IN SILICO APPROACH TO NARROW DOWN SET OF ANTIBODIES SIGNIFICANTLY IMPROVES LIKELIHOOD OF RAPIDLY MANUFACTURING HIGH-QUALITY BIOTHERAPEUTICS

* NO FINANCIAL DETAILS OF AGREEMENT WERE DISCLOSED Source text for Eikon: Further company coverage: (Berlin Speed Desk)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below